Hologenomic analysis of rectal mucus sampling for detection of adenomatous polyps and colorectal cancer

Colorectal cancer (CRC) is the fourth most common cancer and the third leading cause of cancer-related mortality worldwide, with incidence rising among younger populations. The significant clinical and economic burden highlights the need for minimally invasive technologies capable of detecting pre-malignant and early-stage disease. Although liquid biopsy approaches have advanced, they have not achieved sufficient performance for clinical adoption when compared with colonoscopy, the current diagnostic gold standard. CRC is a mucosal pathology, yet current diagnostic methods have not leveraged mucosal biology. Here we demonstrate the clinical utility of rectal mucus specimens, collected using a minimally invasive device in an outpatient setting, without bowel preparation. Through a hologenomic approach integrating host and microbial genomics, we identify genetic and epigenetic aberrations and perturbations in microbial communities that drive the detection of adenomatous polyps and CRC in rectal mucus. Hologenomic integration enables superior stratification of CRC by disease site and stage compared with single-omics methods. In summary, we demonstrate the clinical utility of rectal mucus sampling combined with hologenomic analysis as a translatable prospective tool for diagnostic application.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-12-04
DOI
https://doi.org/10.1038/s41467-025-66006-1
Citations
1
Primary Topic
Colorectal Cancer Screening and Detection
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hologenomic analysis of rectal mucus sampling for detection of adenomatous polyps and colorectal cancer

Daniel G. Wise, H Rottenburg, Chris Cunningham, Andrew J. Tock et al.
1 citations
Nature Communications
Colorectal Cancer Screening and Detection
1.05
article

Hologenomic analysis of rectal mucus sampling for detection of adenomatous polyps and colorectal cancer

Daniel G. Wise, H Rottenburg, Chris Cunningham, Andrew J. Tock, Katerina-Vanessa Savva, L.J. Zhang, Catarina Inês Mendes, Nick Battersby, Jon Lacy‐Colson, Ana Crespillo-Casado, Melissa L. Siew, Ernest H. Law, Stephen Njoroge, Hannah N. Humphrey, Megan Sands, Alice Baggaley, Sue Spencer, Dave Baker, Christopher John Peters, Frank McDermott, Guy Mozolowski, I. R. Daniels, Heena Sisodia, Hugo G G Lywood, Oladapo E. Olaniru, Andrew J. Page, Kiran Kang, S Bird, Kirtan Patel, Chris Hamon, Gareth A. R. Jones, Andrew Dodd, Eleanor T. Walker-Davies, Chris Orthodoxou, Alasdair D. MacRitchie, Emma Morales-Walker
article en
1 citations

Abstract

Colorectal cancer (CRC) is the fourth most common cancer and the third leading cause of cancer-related mortality worldwide, with incidence rising among younger populations. The significant clinical and economic burden highlights the need for minimally invasive technologies capable of detecting pre-malignant and early-stage disease. Although liquid biopsy approaches have advanced, they have not achieved sufficient performance for clinical adoption when compared with colonoscopy, the current diagnostic gold standard. CRC is a mucosal pathology, yet current diagnostic methods have not leveraged mucosal biology. Here we demonstrate the clinical utility of rectal mucus specimens, collected using a minimally invasive device in an outpatient setting, without bowel preparation. Through a hologenomic approach integrating host and microbial genomics, we identify genetic and epigenetic aberrations and perturbations in microbial communities that drive the detection of adenomatous polyps and CRC in rectal mucus. Hologenomic integration enables superior stratification of CRC by disease site and stage compared with single-omics methods. In summary, we demonstrate the clinical utility of rectal mucus sampling combined with hologenomic analysis as a translatable prospective tool for diagnostic application.

Nature CommunicationsVol. 16(1)
University of East Anglia (GB), Royal Devon & Exeter NHS Foundation Trust (GB), Royal Cornwall Hospital (GB), John Radcliffe Hospital (GB), Quadram Institute (GB), Origin Sciences (United Kingdom) (GB), Granta Design (United Kingdom) (GB), Advanced Emissions Solutions (United States) (US), Shrewsbury and Telford Hospital NHS Trust (GB), Imperial College London (GB)
Openalex Percentile: Top 15%
Colorectal Cancer Screening and Detection
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.